168 related articles for article (PubMed ID: 35293653)
1. Minimum criteria for defining induced mesenchymal stem cells.
Choudhery MS; Mahmood R; Harris DT; Ahmad FJ
Cell Biol Int; 2022 Jun; 46(6):986-989. PubMed ID: 35293653
[TBL] [Abstract][Full Text] [Related]
2. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
Xu M; Shaw G; Murphy M; Barry F
Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
[TBL] [Abstract][Full Text] [Related]
3. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells.
Wang Q; Wang Y; Chang C; Ma F; Peng D; Yang S; An Y; Deng Q; Wang Q; Gao F; Wang F; Tang H; Qi X; Jiang X; Cai D; Zhou G
Heliyon; 2023 Jan; 9(1):e12683. PubMed ID: 36647346
[TBL] [Abstract][Full Text] [Related]
5. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
[TBL] [Abstract][Full Text] [Related]
6. Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells.
Luo L; Zhou Y; Zhang C; Huang J; Du J; Liao J; Bergholt NL; Bünger C; Xu F; Lin L; Tong G; Zhou G; Luo Y
Stem Cell Res; 2020 Oct; 48():101990. PubMed ID: 32950887
[TBL] [Abstract][Full Text] [Related]
7. Efficient induction of pluripotent stem cells differentiated into mesenchymal stem cell lineages.
Tseng HC; Hsu TF; Lin YY; Lai WY; Liu YH; Yang YP; Chen CF; Wang CY
J Chin Med Assoc; 2024 Mar; 87(3):267-272. PubMed ID: 38277620
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells.
Rajasingh S; Sigamani V; Selvam V; Gurusamy N; Kirankumar S; Vasanthan J; Rajasingh J
J Cell Mol Med; 2021 Sep; 25(18):8904-8919. PubMed ID: 34390186
[TBL] [Abstract][Full Text] [Related]
9. Genetic barcoding reveals clonal dominance in iPSC-derived mesenchymal stromal cells.
Hollmann J; Brecht J; Goetzke R; Franzen J; Selich A; Schmidt M; Eipel M; Ostrowska A; Hapala J; Fernandez-Rebollo E; Müller-Newen G; Rothe M; Eggermann T; Zenke M; Wagner W
Stem Cell Res Ther; 2020 Mar; 11(1):105. PubMed ID: 32138773
[TBL] [Abstract][Full Text] [Related]
10. Human iPSC-derived mesenchymal stem cells encapsulated in PEGDA hydrogels mature into valve interstitial-like cells.
Nachlas ALY; Li S; Jha R; Singh M; Xu C; Davis ME
Acta Biomater; 2018 Apr; 71():235-246. PubMed ID: 29505894
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential.
Zheng YL; Sun YP; Zhang H; Liu WJ; Jiang R; Li WY; Zheng YH; Zhang ZG
PLoS One; 2015; 10(12):e0144226. PubMed ID: 26649753
[TBL] [Abstract][Full Text] [Related]
12. The study of cancer cell in stromal environment through induced pluripotent stem cell-derived mesenchymal stem cells.
Loh JK; Wang ML; Cheong SK; Tsai FT; Huang SH; Wu JR; Yang YP; Chiou SH; Ong AH
J Chin Med Assoc; 2022 Aug; 85(8):821-830. PubMed ID: 35666590
[TBL] [Abstract][Full Text] [Related]
13. Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells.
Dupuis V; Oltra E
World J Stem Cells; 2021 Aug; 13(8):1094-1111. PubMed ID: 34567428
[TBL] [Abstract][Full Text] [Related]
14. Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies.
Gong M; Bi Y; Jiang W; Zhang Y; Chen L; Hou N; Liu Y; Wei X; Chen J; Li T
J Biomed Sci; 2011 Nov; 18(1):87. PubMed ID: 22118013
[TBL] [Abstract][Full Text] [Related]
15. iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs.
Lee HR; Kim S; Shin S; Jeong SY; Lee DW; Lim SU; Kang JY; Son MY; Lee C; Yu KR; Kim M; Oh IH
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614321
[TBL] [Abstract][Full Text] [Related]
16. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells.
Jeong J; Shin K; Lee SB; Lee DR; Kwon H
Exp Mol Pathol; 2014 Oct; 97(2):253-8. PubMed ID: 25102299
[TBL] [Abstract][Full Text] [Related]
17. Validation of multiparametric panels for bovine mesenchymal stromal cell phenotyping.
Heyman E; Meeremans M; Van Poucke M; Peelman L; Devriendt B; De Schauwer C
Cytometry A; 2023 Sep; 103(9):744-755. PubMed ID: 37173856
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human isogeneic Wharton's jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation.
Devito L; Klontzas ME; Cvoro A; Galleu A; Simon M; Hobbs C; Dazzi F; Mantalaris A; Khalaf Y; Ilic D
Cell Death Dis; 2019 Mar; 10(4):277. PubMed ID: 30894508
[TBL] [Abstract][Full Text] [Related]
19. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
Dominici M; Le Blanc K; Mueller I; Slaper-Cortenbach I; Marini F; Krause D; Deans R; Keating A; Prockop Dj; Horwitz E
Cytotherapy; 2006; 8(4):315-7. PubMed ID: 16923606
[TBL] [Abstract][Full Text] [Related]
20. Differentiating Induced Pluripotent Stem Cells Toward Mesenchymal Stem/Stromal Cells.
McGarvey SS; Ferreyros M; Kogut I; Bilousova G
Methods Mol Biol; 2022; 2549():153-167. PubMed ID: 33772462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
